tiprankstipranks

OrbiMed Investment Portfolio

OrbiMed (OrbiMed Advisors) is an American investment firm based in New York City, United States. It is focused on making public and private investments in the Healthcare and Biotechnology industries. OrbiMed is considered one of the worlds largest dedicated healthcare investment firms.

Companies Invested In

Company Name
Sector
Investment Round Value
Funding Round
Announcement Date
Healthcare, Biotechnology & Medical Devices
$100.00M
Investment
Mar 04, 2025
Healthcare, Biotechnology & Medical Devices
$50.00M
Growth Round
Oct 09, 2025
Healthcare, Biotechnology & Medical Devices
$115.00M
Series C
Nov 20, 2025
Healthcare, Biotechnology & Medical Devices
$60.00M
Series B
Sep 22, 2025
Healthcare, Biotechnology & Medical Devices
$84.00M
Series B
Dec 10, 2025
Healthcare, Biotechnology & Medical Devices
$185.00M
Series A
Nov 05, 2025
Healthcare, Biotechnology & Medical Devices
$80.00M
Series B
Sep 02, 2025
Healthcare, Biotechnology & Medical Devices
$32.00M
Investment
Sep 04, 2025
Healthcare, Biotechnology & Medical Devices
$183.00M
Series C
Oct 22, 2025
Healthcare, Biotechnology & Medical Devices
$60.00M
Series B
Sep 08, 2025
Healthcare, Biotechnology & Medical Devices
$45.00M
Investment
Aug 14, 2025
Healthcare, Biotechnology & Medical Devices
$131.00M
Investment
Aug 14, 2025
Healthcare, Biotechnology & Medical Devices
$250.00M
Series B
Jan 12, 2026
Healthcare, Biotechnology & Medical Devices
$140.00M
Series A
Aug 14, 2025
Healthcare, Biotechnology & Medical Devices
$89.00M
Series B
Mar 26, 2026
Healthcare, Biotechnology & Medical Devices
$70.00M
Series A
Dec 11, 2025
Healthcare, Biotechnology & Medical Devices
$80.00M
Series B
Aug 25, 2025
Healthcare, Biotechnology & Medical Devices
$100.00M
Series C
Mar 03, 2025
Healthcare, Biotechnology & Medical Devices
$500.00M
Investment
Apr 02, 2026
Healthcare, Biotechnology & Medical Devices
$95.00M
Series B
Sep 24, 2025
Healthcare, Biotechnology & Medical Devices
$200.00M
Series A
Sep 03, 2025
Healthcare, Biotechnology & Medical Devices
$115.00M
Series B
Aug 14, 2025